Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this GEN webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology. The post Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows appeared first on GEN - Genetic Engineering and Biotechnology News .
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
Guidelines stress the necessity of biomarker testing in metastatic non-small cell lung cancer (NSCLC) treatment. Droplet Digital PCR (ddPCR) has gained prominence in research involving both solid and liquid cancer samples due to its ability to detect and quantify nucleic acid targets with remarkable sensitivity. This capability supports critical oncology research such as biomarker characterization and molecular profiling.
During a recent GEN webinar, experts Prithwish Pal, PhD, and Surbhi Jain, PhD, MBBS, delved into the expanding role of ddPCR in clinical research and translational oncology. Pal discussed the utility of ddPCR in liquid biopsy applications demanding high sensitivity. Jain, as the staff scientist and R&D lead for the ddPLEX EGFR/KRAS/BRAF multiplexed droplet digital PCR panel at Bio-Rad Laboratories, highlighted her team's focus on developing ddPCR assay solutions for precision oncology.
With over 16 years of experience in diagnostic assay development, Jain possesses expertise in liquid biopsy biomarkers and high-throughput molecular workflows.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
